The biggest cannabis holiday of the year is here! Since 4/20 falls on Easter Sunday, Nature's Remedy Cannabis is throwing an unforgettable 4/20 Bash on Saturday, April 19th, packed with exclusive deals, giveaways, food, music, and more!
Read MoreDuane Boise CEO of MMJ International Holdings stated, “When private citizens or companies fall short of compliance, the DEA acts swiftly and decisively. The question is, why is there no comparable urgency when the failure comes from within the DEA's own ranks? The agency's silence on this matter is not just a public relations problem—it's a breach of public trust."
Read MoreCentral to the probe are DEA's Thomas Prevoznik, DEA's Matthew Strait and DEA attorney Aarathi Haig within the DEA's Diversion Control Division, whose conduct has raised serious questions about the integrity of the DEA's regulatory processes.
Read More
"This is insanity," declares Duane Boise, CEO of MMJ International Holdings, echoing the sentiments of lawmakers and researchers alike. The 2020 House Oversight Committee hearing, and ongoing developments, have laid bare the Drug Enforcement Administration's (DEA) persistent obstruction of legitimate cannabis research, a battle MMJ has been fighting since their 2018 application. Despite bipartisan congressional outrage, as highlighted by Representative Earl "Buddy" Carter's scathing critique of the DEA's "epitome of ineptitude," and the agency's own hollow defenses, the DEA, represented by figures like Matthew Strait and Thomas Prevoznik, continues to delay and deny, hindering vital medical advancements. Boise's lawsuit against the DEA underscores the urgent need for reform, as the agency's actions not only impede scientific progress but also deny patients access to potentially life-changing treatments, a situation that demands immediate structural changes in federal cannabis policy.
Read MoreAs a leader in integrative mental health and the nation's first legal psilocybin therapy center, Bionic Bloom's mission aligns seamlessly with Cannadelic's commitment to holistic well-being and cutting-edge therapies.
Read MoreThe DEA is "out of touch" and resistant to reform, stated Ben Kovler. Yet, amid this uncertainty, MMJ International Holdings has charted a distinct course-one rooted in pharmaceutical rigor-that's positioning the company as a trailblazer in the medical cannabis space.
Read MoreThe Department of Justice (DOJ) has announced that it will no longer defend statutory protections that currently shield Administrative Law Judges (ALJs) from removal. This significant shift is expected to bolster MMJ International Holdings' ongoing lawsuit against the Drug Enforcement Administration (DEA), which has been criticized for stalling MMJ's application to cultivate pharmaceutical-grade marijuana for medical research.
Read MoreNewly Formed Executive Team to Share Corporate Transformation Strategy and Technology Differentiation; Interactive Session Will Address Upcoming Milestones and Growth Initiatives
Read MoreBlockchain Pioneer and Public Markets Executive Frank Yglesias Appointed CEO of Pineapple Express Cannabis Company (OTC: PNXP); Strategic Relocation to Atlanta Tech Hub Signals Transformation into Cannabis Authentication Technology Leader, Launching Revolutionary GROOVY Platform for Product Safety and Consumer Rewards.
Read MoreFDA-Compliant Clinical Trials:
MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to validate the safety and efficacy of cannabis-derived therapeutics for use in human clinical trials for Huntington's disease patients.
MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has obstructed domestic cannabis research despite the Right To Try and the Medical Marijuana Research Expansion Act. MMJ accuses the DEA of bias in restricting MMJ to cultivate its proprietary marijuana cultivars necessary for research and pharmaceutical drug manufacturing. A pending federal court ruling in Rhode Island will set a significant precedent, challenging DEA authority and potentially easing regulatory barriers for MMJ's future cannabinoid drug development.
Read MorePioneer Green Farms is a PIONEER in the Florida hemp market, having received its original license in 2020, and the only indoor hemp license in Southwest Florida
Pioneer Green Farms has planted its first indoor hemp crop with six (6) proprietary hemp strains in Florida
Pioneer Green Farms has strong growth potential as the initial hemp crop utilizes three (3) out of twenty (20) indoor growing rooms
Pioneer Green Farms indoor growing facility has an annual capacity of 20,000 pounds of h
HYMAN Cannabis Partners with Golf Icon John Daly to Launch 'Fairway Runtz' Collection – A Bold, Premium Line Celebrating Daly’s Legendary Style and Michigan’s Cannabis Culture.
Read MoreDuane Boise, President of MMJ BioPharma Cultivation, stated, "I think most Americans want judges who don't mind telling the truth and don't mind saying we're wrong. Unlike the DEA's arrogant attitude of, if we make a mistake, we won't be called on it, however MMJ is doing exactly that. The most immature thing you can do is say, 'no, no, I didn't make a mistake.' The mature thing to do, that all adults learn to do in this country is to say, 'oops, that was a mistake. I'm going to fix it. I'm sorry.'"
Read MoreMarijuana Rescheduling Process Normally Steered by the DEA had been taken over by the U.S. Justice Department. The decision would not be signed by DEA ANNE MILGRAM but by Attorney General Merrick Garland.